Journal
THERAPIE
Volume 76, Issue 4, Pages 365-367Publisher
ELSEVIER
DOI: 10.1016/j.therap.2021.03.005
Keywords
Type I interferons; COVID-19 vaccines; Bell's palsy; Phase 3 clinical trials; Pharmacovigilance